Literature DB >> 17308131

Women's health and the metabolic syndrome.

Asimina Mitrakou1.   

Abstract

The metabolic syndrome is a cluster of cardiovascular risk factors that identifies individuals at a relatively high, long-term risk for atherosclerosis, cardiovascular disease, and type 2 diabetes. Insulin resistance and central obesity are the main risk conditions underlying the metabolic syndrome. As obesity rates increase worldwide especially in women, accompanying rising frequency of insulin resistance, dyslipidemia, diabetes, and hypertension contribute to increasing rates of cardiovascular morbidity and mortality. According to the latest NCEP/ATPIII definition of the metabolic syndrome almost 25% (from 6.7 up to 43.5% according to age) of the United States and European adult population appear to have the syndrome and in the recent years it has been more prevalent in men than in women. Prevalence is increasing and the increase seems to be steeper in women. The contribution of the different components of the syndrome differs between genders. Age, endocrine dysfunction (especially loss of ovarian estrogens) as well as genetic factors modify the response to underlying factors. Physical inactivity, which diminishes by age, is more prevalent in women than in men. Treatment goals are to prevent cardiovascular disease by both altering the risk factors that are components of the syndrome and more importantly applying lifestyle modifications with caloric restriction and exercise.

Entities:  

Mesh:

Year:  2006        PMID: 17308131     DOI: 10.1196/annals.1365.003

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Empirical evidence for "syndrome Z": a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures.

Authors:  Nora L Nock; Li Li; Emma K Larkin; Sanjay R Patel; Susan Redline
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

2.  A methodology for multivariate phenotype-based genome-wide association studies to mine pleiotropic genes.

Authors:  Sung Hee Park; Ji Young Lee; Sangsoo Kim
Journal:  BMC Syst Biol       Date:  2011-12-14

3.  Sleep duration and breast cancer phenotype.

Authors:  Ali Khawaja; Santosh Rao; Li Li; Cheryl L Thompson
Journal:  J Cancer Epidemiol       Date:  2013-11-04

4.  Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women.

Authors:  Arcangelo Iannuzzi; Francesco Giallauria; Marco Gentile; Paolo Rubba; Giuseppe Covetti; Alessandro Bresciani; Emilio Aliberti; Gilanluigi Cuomo; Camilla Panico; Maria Tripaldella; Maria Ausilia Giusti; Alessandro Mattina; Gabriella Iannuzzo
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

5.  Defining genetic determinants of the Metabolic Syndrome in the Framingham Heart Study using association and structural equation modeling methods.

Authors:  Nora L Nock; Xuefeng Wang; Cheryl L Thompson; Yeunjoo Song; Dan Baechle; Paola Raska; Catherine M Stein; Courtney Gray-McGuire
Journal:  BMC Proc       Date:  2009-12-15

6.  Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.

Authors:  Jorge Escobedo; Herman Schargrodsky; Beatriz Champagne; Honorio Silva; Carlos P Boissonnet; Raul Vinueza; Marta Torres; Rafael Hernandez; Elinor Wilson
Journal:  Cardiovasc Diabetol       Date:  2009-09-26       Impact factor: 9.951

7.  Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.

Authors:  Jean-Jacques Mourad; Dulce Lameira; Pierre-Jean Guillausseau
Journal:  Vasc Health Risk Manag       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.